Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4 Recurrence 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Locally Advanced Breast Cancer 1 Cholangiocarcinoma 1 Breast Neoplasms 1

Interventions

Gemcitabine 58 Cisplatin 32 Oxaliplatin 28 Fluorouracil 21 lenvatinib 19 durvalumab 18 Capecitabine 17 Leucovorin 15 tislelizumab 10 pembrolizumab 10 apatinib 9 Floxuridine 8 Specimen Handling 7 Panitumumab 7 Magnetic Resonance Spectroscopy 7 Albumin-Bound Paclitaxel 7 sintilimab 6 pemigatinib 6 Radiotherapy 6 Irinotecan 6 Drug Therapy 6 Biopsy 6 tremelimumab 5 regorafenib 5 olaparib 5 camrelizumab 5 Taxes 5 S 1 (combination) 5 Nivolumab 5 Folfox protocol 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cholangiocarcinoma × Clinical Protocols × Clear all

NCT05557578 2025-02-11

GOT

Zhejiang Cancer Hospital

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡